NCT00203450.
Methods | Randomised controlled trial |
Participants | Individuals who have a body mass index (BMI) > 25 and are on a psychotropic medication with a known side effect of weight gain |
Interventions |
|
Outcomes | Primary outcome: comparison of the efficacy of zonisamide (Zonegran; 100 mg to 400 mg/d) vs placebo as an adjunctive agent for lowering weight |
Notes | No results available |